An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancerHOTTA, Katsuyuki; UEOKA, Hiroshi; KIURA, Katsuyuki et al.Lung cancer. 2004, Vol 46, Num 1, pp 61-76, issn 0169-5002, 16 p.Article

Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective responseFUJII, Masanori; HOTTA, Katsuyuki; TAKIGAWA, Nagio et al.Lung cancer. 2012, Vol 78, Num 1, pp 107-111, issn 0169-5002, 5 p.Article

Aberrant promoter hypermethylation in serum DNA from patients with silicosisUMEMURA, Shigeki; FUJIMOTO, Nobukazu; UEOKA, Hiroshi et al.Carcinogenesis (New York. Print). 2008, Vol 29, Num 9, pp 1845-1849, issn 0143-3334, 5 p.Article

Gefitinib induces premature senescence in non-small cell lung cancer cells with or without EGFR gene mutationHOTTA, Katsuyuki; TABATA, Masahiro; TANIMOTO, Mitsune et al.Oncology reports. 2007, Vol 17, Num 2, pp 313-317, issn 1021-335X, 5 p.Article

Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapyHOTTA, Katsuyuki; FUJIWARA, Yoshiro; MATSUO, Keitaro et al.Cancer. 2007, Vol 109, Num 5, pp 939-948, issn 0008-543X, 10 p.Article

The combination effect of amrubicin with cisplatin or irinotecan for small-cell lung cancer cellsTAKIGAWA, Nagio; TAKEYAMA, Masako; KIURA, Katsuyuki et al.Oncology reports. 2006, Vol 15, Num 4, pp 837-842, issn 1021-335X, 6 p.Article

A phase I study and pharmacokinetics of irinotecan (CPT-11) and paclitaxel in patients with advanced non-small cell lung cancerHOTTA, Katsuyuki; UEOKA, Hiroshi; TANIMOTO, Mitsune et al.Lung cancer. 2004, Vol 45, Num 1, pp 77-84, issn 0169-5002, 8 p.Article

Thrombocytosis as a useful prognostic indicator in patients with lung cancerAOE, Keisuke; HIRAKI, Akio; UEOKA, Hiroshi et al.Respiration (Basel). 2004, Vol 71, Num 2, pp 170-173, issn 0025-7931, 4 p.Article

Axillary metastasis as the first manifestation of occult breast cancer in a man: A case reportNAMBA, Noriko; HIRAKI, Akio; TABATA, Masahiro et al.Anticancer research. 2002, Vol 22, Num 6B, pp 3611-3613, issn 0250-7005, 3 p.Article

Inhibition of NF-κB and proteasome activity in tumors: Can we improve the therapeutic potential of topoisomerase I and topoisomerase II poisonsGANAPATHI, Ram; VAZIRI, Susan A. J; TABATA, Masahiro et al.Current pharmaceutical design. 2002, Vol 8, Num 22, pp 1945-1958, issn 1381-6128Article

Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancerTAKIGAWA, Nagio; SEGAWA, Yoshihiko; UEOKA, Hiroshi et al.Cancer chemotherapy and pharmacology. 2000, Vol 46, Num 4, pp 272-278, issn 0344-5704Article

Association of the benefit from gefitinib monotherapy with smoking status in Japanese patients with non-small-cell lung cancerHOTTA, Katsuyuki; KIURA, Katsuyuki; TAKIGAWA, Nagio et al.Lung cancer. 2008, Vol 62, Num 2, pp 236-241, issn 0169-5002, 6 p.Article

Isolated metastasis of lung cancer to the thyroid glandOSAWA, Masahiro; TAKIGAWA, Nagio; KIURA, Katsuyuki et al.Lung cancer. 2007, Vol 58, Num 1, pp 156-158, issn 0169-5002, 3 p.Article

Clustered incidence of acute promyelocytic leukemia during gefitinib treatment for non-small-cell lung cancer : Experience at a single institutionMATSUO, Keitaro; KIURA, Katsuyuki; SHINAGAWA, Katsuji et al.American journal of hematology. 2006, Vol 81, Num 5, pp 349-354, issn 0361-8609, 6 p.Article

Successful treatment of a patient with gastric and duodenal metastases from large cell carcinoma of the lung with carboplatin and gemcitabineOHASHI, Kadoaki; KIURA, Katsuyuki; TAKIGAWA, Nagio et al.Anticancer research. 2006, Vol 26, Num 6C, pp 4695-4696, issn 0250-7005, 2 p.Article

Identification of epigenetic aberrant promoter Methylation in serum DNA is useful for early detection of lung cancerFUJIWARA, Keiichi; FUJIMOTO, Nobukazu; TANIMOTO, Mitsune et al.Clinical cancer research. 2005, Vol 11, Num 3, pp 1219-1225, issn 1078-0432, 7 p.Article

The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancersTOKUMO, Masaki; TOYOOKA, Shinichi; TABATA, Masahiro et al.Clinical cancer research. 2005, Vol 11, Num 3, pp 1167-1173, issn 1078-0432, 7 p.Article

Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patientsTAKIGAWA, Nagio; SEGAWA, Yoshihiko; GEMBA, Kenichi et al.Cancer chemotherapy and pharmacology. 2004, Vol 54, Num 3, pp 230-236, issn 0344-5704, 7 p.Article

Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancerSEGAWA, Yoshihiko; UEOKA, Hiroshi; HIRAKI, Shunkichi et al.Lung cancer. 2003, Vol 41, Num 1, pp 13-20, issn 0169-5002, 8 p.Article

Synergistic effects of topoisomerase I inhibitor, 7-ethyl-10-hydroxycamptothecin, and irradiation in a cisplatin-resistant human small cell lung cancer cell lineKOHARA, Hiroyuki; TABATA, Masahiro; KIURA, Katsuyuki et al.Clinical cancer research. 2002, Vol 8, Num 1, pp 287-292, issn 1078-0432Article

A phase I study of S-1 with concurrent thoracic radiotherapy in elderly patients with localized advanced non-small cell lung cancerTAKIGAWA, Nagio; KIURA, Katsuyuki; HIMEI, Kengo et al.Lung cancer. 2011, Vol 71, Num 1, pp 60-64, issn 0169-5002, 5 p.Article

Sex difference in the influence of smoking status on the responsiveness to gefitinib monotherapy in adenocarcinoma of the lung : Okayama Lung Cancer Study Group experienceHOTTA, Katsuyuki; KIURA, Katsuyuki; KAMEI, Haruhito et al.Journal of cancer research and clinical oncology. 2009, Vol 135, Num 1, pp 117-123, issn 0171-5216, 7 p.Article

Elevated serum level of sialylated glycoprotein KL-6 predicts a poor prognosis in patients with non-small cell lung cancer treated with gefitinibFUJIWARA, Yoshiro; KIURA, Katsuyuki; DATE, Hiroshi et al.Lung cancer. 2008, Vol 59, Num 1, pp 81-87, issn 0169-5002, 7 p.Article

A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancerTABATA, Masahiro; KIURA, Katsuyuki; TANIMOTO, Mitsune et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 1, pp 1-6, issn 0344-5704, 6 p.Article

Point mutation of K-ras gene in cisplatin-induced lung tumours in A/J miceHISAMOTO, Akiko; KONDO, Eisei; KIURA, Katsuyuki et al.Lung cancer. 2007, Vol 58, Num 1, pp 15-20, issn 0169-5002, 6 p.Article